Since the pandemic, top HR leaders have increasingly encountered hesitation from potential successors. They are dipping into less experienced, early-career candidates for the CHRO slot, HR experts say.
The 'staggering' cost of pharmacy drugs is driving most of the increase, says Ellen Kelsay of the Business Group on Health, which released new data this week.